Skip to main content

Products

Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.

Connect With Us

All Products (172)

Clear all filters
Clear all filters

Givinostat

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Hematologic (Lymphoma)

Drug Class / Mechanism

HDAC Inhibitor

Iberdomide

Immunomodulatory Agent

Therapeutic Category

Immunomodulatory Agent

Oncology Type

Hematologic (Multiple Myeloma)

Drug Class / Mechanism

IMiD (Cereblon Modulator)

Ilginatinib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Hematologic (MPN)

Drug Class / Mechanism

JAK Inhibitor

Imatinib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Hematologic (Leukemia)

Drug Class / Mechanism

BCR-ABL Tyrosine Kinase Inhibitor

Imetelstat

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Hematologic (MDS)

Drug Class / Mechanism

Oligonucleotide Telomerase Inhibitor (first-in-class)

Inotuzumab Ozogamicin

Targeted Therapy (Antibody-Drug Conjugate)

Therapeutic Category

Targeted Therapy (Antibody-Drug Conjugate)

Oncology Type

Hematologic

Drug Class / Mechanism

ADC

Isatuximab

Immunotherapy (Monoclonal Antibody)

Therapeutic Category

Immunotherapy (Monoclonal Antibody)

Oncology Type

Hematologic (Multiple Myeloma)

Drug Class / Mechanism

Anti-CD38 / SLAMF7 mAb

Itacitinib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Hematologic (MPN)

Drug Class / Mechanism

JAK Inhibitor

Ixazomib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Hematologic (Multiple Myeloma)

Drug Class / Mechanism

Proteasome Inhibitor

Jaktinib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Hematologic (MPN)

Drug Class / Mechanism

JAK Inhibitor

Lanraplenib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Hematologic

Drug Class / Mechanism

SYK / Multi-Kinase Inhibitor

Lisaftoclax

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Hematologic

Drug Class / Mechanism

BCL-2 Inhibitor